Pharmafile Logo
Pharmafocus logo
Advanced Search

PPRS

Showing 6 posts of 36 posts found.

NHS Confederation: value-based pricing could increase NHS costs

March 18, 2011
Sales and Marketing NHS Confederation, PPRS, Pharmaceutical Price Regulation Scheme, UK drug pricing, VBP, value-based pricing

Government plans to introduce value-based pricing in the UK could increase the NHS drugs bill without improving the effectiveness of …

News
Association of the British Pharmaceutical Industry

Pharma industry wary of UK drug pricing changes

March 17, 2011
Sales and Marketing ABPI, National Voices, PPRS, Pharmaceutical Price Regulation Scheme, Simon Jose, UK drug pricing, VBP, value-based pricing

The ABPI wants the current drug pricing system to remain, but has welcomed government proposals to take a broader view …

News
ABPI

Value-based pricing no ‘magic bullet’ – ABPI

November 16, 2010
Sales and Marketing ABPI, Dr Richard Barker, NHS drug sales, PPRS, UK medicines pricing, value-based pricing

UK pharma association the ABPI has warned that the government’s planned value-based pricing system for medicines will not necessarily save …

News

Minister confirms NICE will be sidelined in drug evaluation

October 26, 2010
Sales and Marketing Andrew Lansley, Lord Howe, NICE, PPRS, medicines pricing, value-based pricing

A health minister has confirmed NICE will be “moved” from its current central role in health technology assessment to make …

News
Rosler and Merkel

Germany and UK to seize control of medicines prices

July 1, 2010
Sales and Marketing Germany, Lansley, PPRS, UK, global pricing, price cuts

 Major changes are afoot in Germany and the UK, the last two European countries with ‘free pricing’ of pharmaceuticals. Governments …

News

PM hints pharma could avoid ‘value-based’ pricing

March 9, 2007
Sales and Marketing PPRS, Tony Blair, value based pricing, value-based pricing

 Tony Blair has suggested that the government will not accept value-based pricing of pharmaceutical products as proposed by the Office …

News

Latest content

GSK pledges £45m to Fleming Initiative to fight AMR

May 16, 2024

NeuroSense partners with PhaseV on upcoming phase 3 ALS trial

May 16, 2024

AstraZeneca adds new heart failure target through collaboration with BenevolentAI

May 15, 2024

FDA approves Roche’s HPV self-collection screening option

May 15, 2024

NHS accepts Pfizer’s tafamidis for ATTR-CM treatment

May 14, 2024